Clik here to view.
Propeller health announces $20M funding round, strategic partnership with...
Today, Madison, Wisconsin-based digital respiratory health company Propeller Health announced a $20 million funding round led by a $10 million investment from Aptar Pharma. Existing investors Safeguard...
View ArticleClik here to view.
Propeller Health, GSK expand partnership, target asthma and COPD
Propeller Health, a company that trains its digital eye on respiratory medicine, first partnered with GSK in 2015. Now, that collaboration is being expanded -- enabling both companies to prepare for,...
View ArticleClik here to view.
FDA clears Adherium's third inhaler sensor, for AstraZeneca's Symbicort inhaler
Melbourne, Australia-based Adherium, a digital health company that focuses in improving medication adherence and patient outcomes, has just received FDA clearance for a new inhaler monitoring device...
View ArticleClik here to view.
Humana to pilot Revon's self-triage app for COPD
Humana has tapped Crestwood, Kentucky-based Revon Systems for a market-wide pilot of the latter’s mobile self-triage platform, the Revon Smart Symptom Tracker. The program aims to help a select...
View ArticleClik here to view.
Pneuma Respiratory debuts smartphone-compatible inhaler
North Carolina-based Pneuma Respiratory has announced a fully digital soft mist inhaler device. The inhaler can deliver several different types of medicines directly to the lungs, and by syncing with a...
View ArticleClik here to view.
Express Scripts, Propeller partner to make inhaler sensor more widely available
Express Scripts members will now have access to Propeller’s FDA-cleared digital platform for respiratory health. Today, the two companies announced a partnership which they claim is the largest...
View ArticleClik here to view.
New ResApp data shows ~90 percent accuracy when diagnosing range of...
Brisbane, Australia-based ResApp is planning to re-do its big US trial soon, but in the meantime the smartphone respiratory diagnosis company is continuing to collect data in its native country.The...
View ArticleClik here to view.
Smartinhaler maker Adherium heads to the US market with D2C push
New Zealand-based smart inhaler company Adherium, which up until now has distributed its products via pharma sales channels in Europe and Australia, plans to expand into the United States in the first...
View ArticleClik here to view.
Study: COPD robot improves medication adherence, but no effect on admissions
A socially assistive robot could be key to helping people with COPD manage their condition at home. A recent study published in JMIR, found that COPD patients that had a take-home a robot following a...
View ArticleClik here to view.
Adherium receives OTC clearance for AstraZeneca's Symbicort inhaler
Smart inhaler company Adherium announced last week that it has received 510(k) clearance for over-the-counter sales of its inhaler monitoring device for AstraZeneca’s Symbicort aerosol inhaler, called...
View ArticleClik here to view.
Propeller Health announces $20M funding round, strategic partnership with...
Today, Madison, Wisconsin-based digital respiratory health company Propeller Health announced a $20 million funding round led by a $10 million investment from Aptar Pharma. Existing investors Safeguard...
View ArticleClik here to view.
Teva's digital inhaler cleared by FDA
Jerusalem-based Teva Pharmaceuticals’ sensor-packed, app-connected digital inhaler has recently received marketing approval from the US FDA, according to a release from the company. The device will...
View ArticleClik here to view.
Propeller Health taps Walgreens as first partner for new My Pharmacy feature
Respiratory health company Propeller Health, which was recently acquired by ResMed for $225 million, announced this week in San Francisco a partnership with Walgreens and a new feature for users of its...
View ArticleClik here to view.
Report: Digital respiratory health market primed for growth, could reach...
While recent news of international product launches and recent M&As might suggest a cutthroat market, new data released this week by Research2Guidance suggest that there is still plenty of room in...
View ArticleClik here to view.
Kaia Health unveils a feasibility study to explore a digital COPD treatment...
Digital therapeutics company Kaia Health has unveiled a feasibility study to examine the impact of its digital therapeutic treatment of Chronic Obstructive Pulmonary Disease (COPD) on Japan’s ageing...
View ArticleClik here to view.
Big data emphasis underpins Teva's plans for smart inhaler, clinical trial...
At MEDinIsrael 2019 this week, a conference in Tel Aviv sponsored by the Israeli Export Institute, Dr. Lena Granovsky, director of analytics and big data at Teva Pharmaceuticals, spoke on and off stage...
View ArticleClik here to view.
FDA clears Spry Health's remote monitoring wearable for COPD patients
The Loop System, a continuous remote monitor developed by Palo Alto-based startup Spry Health, received 510(k) clearance from the FDA last Friday, according to an update to the agency’s database that...
View ArticleSatellite Applications Catapult and NHS organisation strengthen partnership
Innovation and tech company Satellite Applications Catapult and the NHS Arden and Greater East Midlands Commissioning Support Unit (CSU) announced this week that they have agreed a formal partnership...
View ArticleFDA clears Propeller Health sensor for use with AstraZeneca's Symbicort inhaler
Digital respiratory health company Propeller Health has received 510(k) clearance for a sensor and app intended for use with AstraZeneca's Symbicort inhaler for asthma and COPD, the company announced...
View ArticleTeva Pharmaceuticals releases its prescription ProAir Digihaler in the US
Jerusalem-based Teva Pharmaceuticals announced this week the U.S. launch of its ProAir Digihaler.The sensor-laden albuterol dispenser requires a prescription, and is indicated for those aged four years...
View Article